European Companies Search Engine
UK funding (£5,400.00): International exploitation of new reagents and assays for antibiotic discovery Ukri20 Jul 2015 UK Research and Innovation, United Kingdom
Overview
Text
International exploitation of new reagents and assays for antibiotic discovery
| Abstract | USA |
| Category | Research Grant |
| Reference | BB/N00390X/1 |
| Status | Closed |
| Funded period start | 20/07/2015 |
| Funded period end | 19/07/2016 |
| Funded value | £5,400.00 |
| Source | https://gtr.ukri.org/projects?ref=BB%2FN00390X%2F1 |
Participating Organisations
| University of Warwick | |
| University of Cape Town | |
| Entasis Therapeutics | |
| Merck & Co., Inc. (Sharp & Dohme (MSD)) | |
| McMaster University | |
| University of Queensland | |
| Novartis Pharma AG |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: University of Warwick, Coventry.
